Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.
about
Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase.Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPasesNMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micellesThe anti-apoptotic protein HAX-1 is a regulator of cardiac functionThe alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.Locating phospholamban in co-crystals with Ca(2+)-ATPase by cryoelectron microscopySarco(endo)plasmic reticulum calcium pumps: recent advances in our understanding of structure/function and biology (review).Discovery and structural characterization of a phospholamban-binding cyclic peptide and design of novel inhibitors of phospholamban.Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pumpStructural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase.Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbonePhospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells.Structure of the 1-36 N-terminal fragment of human phospholamban phosphorylated at Ser-16 and Thr-17.Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents.Physical interactions between phospholamban and sarco(endo)plasmic reticulum Ca2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP.Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.Solid-state NMR reveals structural changes in phospholamban accompanying the functional regulation of Ca2+-ATPase
P2860
Q24541329-C3BFE2E9-79E0-4F39-9C21-A1428259C175Q24555223-52DA0E56-E902-4B17-A736-1770ECCD1F42Q27642223-00A1DE59-9E50-4FC0-934B-DF90BFA736D1Q28579303-E610E0EA-3E81-4011-A38C-D51A43EAE7BBQ30984765-7CF550AC-C73D-4685-96D6-1DD84FED77ECQ34176103-C2FF3A6C-0D55-4474-A137-7BB2D5D7F386Q34219003-6D606E1D-8DBA-4684-B192-7A67E0297B80Q34266350-DDDE6B98-B6A0-41BD-A9D1-37C583AECD9FQ35063543-6722BC09-161A-4F7D-B97C-F5680C1E151AQ37032523-17BE0DFD-3914-4CFB-A875-0BC3259CB593Q37569037-6B9B224B-649A-4D41-805B-9B6FCB137714Q40011138-635D0DF1-A7C7-46E0-9DD3-8357650C7465Q40210581-9563B276-1E08-4479-8339-3BDECB3BCDFBQ40634835-EDA69646-FC88-4A50-8BA6-5432DD883A40Q40880128-9DC5E50E-7419-494A-BECF-E40AE1BA1DD6Q40890052-0719B2FD-1FD4-43A4-8AAC-1C5A98713A4DQ57101089-07C176DB-A41F-4716-9E4F-68666A40CF1A
P2860
Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Structure of the 1-36 amino-te ...... of the phospholamban pentamer.
@en
type
label
Structure of the 1-36 amino-te ...... of the phospholamban pentamer.
@en
prefLabel
Structure of the 1-36 amino-te ...... of the phospholamban pentamer.
@en
P2093
P2860
P1433
P1476
Structure of the 1-36 amino-te ...... of the phospholamban pentamer.
@en
P2093
P2860
P304
P356
10.1016/S0006-3495(99)77339-X
P407
P577
1999-04-01T00:00:00Z